nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—Central nervous system disorder—Glyburide—gestational diabetes	0.0424	0.136	CcSEcCtD
Isotretinoin—Vitamin A—RBP4—gestational diabetes	0.0385	1	CrCbGaD
Isotretinoin—Allergic cutaneous angiitis—Glyburide—gestational diabetes	0.0268	0.0861	CcSEcCtD
Isotretinoin—RARG—Vitamin A and Carotenoid Metabolism—RBP4—gestational diabetes	0.0208	0.0431	CbGpPWpGaD
Isotretinoin—RXRB—islet of Langerhans—gestational diabetes	0.0199	0.118	CbGeAlD
Isotretinoin—RXRG—Vitamin A and Carotenoid Metabolism—RBP4—gestational diabetes	0.019	0.0394	CbGpPWpGaD
Isotretinoin—RARB—Vitamin A and Carotenoid Metabolism—RBP4—gestational diabetes	0.0186	0.0386	CbGpPWpGaD
Isotretinoin—RARA—Vitamin A and Carotenoid Metabolism—RBP4—gestational diabetes	0.0179	0.037	CbGpPWpGaD
Isotretinoin—RXRB—Vitamin A and Carotenoid Metabolism—RBP4—gestational diabetes	0.0179	0.037	CbGpPWpGaD
Isotretinoin—Leukocytoclastic vasculitis—Glyburide—gestational diabetes	0.0174	0.0559	CcSEcCtD
Isotretinoin—Blindness—Glyburide—gestational diabetes	0.0154	0.0495	CcSEcCtD
Isotretinoin—RXRG—Adipogenesis—RETN—gestational diabetes	0.0147	0.0304	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors—AR—gestational diabetes	0.0145	0.0301	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—RETN—gestational diabetes	0.0138	0.0286	CbGpPWpGaD
Isotretinoin—RXRG—adipose tissue—gestational diabetes	0.0135	0.0802	CbGeAlD
Isotretinoin—RXRG—Nuclear Receptors—AR—gestational diabetes	0.0133	0.0276	CbGpPWpGaD
Isotretinoin—Encephalopathy—Glyburide—gestational diabetes	0.0133	0.0427	CcSEcCtD
Isotretinoin—RARB—Nuclear Receptors—AR—gestational diabetes	0.013	0.027	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors—AR—gestational diabetes	0.0125	0.0259	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptors—AR—gestational diabetes	0.0125	0.0259	CbGpPWpGaD
Isotretinoin—RXRA—head—gestational diabetes	0.0118	0.0701	CbGeAlD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—ADIPOQ—gestational diabetes	0.0117	0.0242	CbGpPWpGaD
Isotretinoin—RARG—uterus—gestational diabetes	0.0115	0.0684	CbGeAlD
Isotretinoin—RARG—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.0115	0.0238	CbGpPWpGaD
Isotretinoin—RARB—vagina—gestational diabetes	0.0115	0.0682	CbGeAlD
Isotretinoin—RARG—adipose tissue—gestational diabetes	0.0113	0.0669	CbGeAlD
Isotretinoin—Coagulopathy—Glyburide—gestational diabetes	0.0109	0.0352	CcSEcCtD
Isotretinoin—RARA—uterus—gestational diabetes	0.0108	0.0643	CbGeAlD
Isotretinoin—RARB—head—gestational diabetes	0.0106	0.063	CbGeAlD
Isotretinoin—RARA—adipose tissue—gestational diabetes	0.0106	0.0629	CbGeAlD
Isotretinoin—RXRB—vagina—gestational diabetes	0.0105	0.0627	CbGeAlD
Isotretinoin—RXRG—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.0105	0.0218	CbGpPWpGaD
Isotretinoin—RXRG—head—gestational diabetes	0.0104	0.0616	CbGeAlD
Isotretinoin—RARB—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.0103	0.0214	CbGpPWpGaD
Isotretinoin—RXRG—Regulation of Androgen receptor activity—AR—gestational diabetes	0.0102	0.0211	CbGpPWpGaD
Isotretinoin—RXRA—Endogenous sterols—CYP19A1—gestational diabetes	0.01	0.0207	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.00988	0.0205	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.00988	0.0205	CbGpPWpGaD
Isotretinoin—RXRB—head—gestational diabetes	0.00973	0.0579	CbGeAlD
Isotretinoin—RXRB—Regulation of Androgen receptor activity—AR—gestational diabetes	0.00958	0.0199	CbGpPWpGaD
Isotretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—gestational diabetes	0.00942	0.0195	CbGpPWpGaD
Isotretinoin—RARG—vagina—gestational diabetes	0.00935	0.0556	CbGeAlD
Isotretinoin—RXRA—Vitamin A and Carotenoid Metabolism—RBP4—gestational diabetes	0.00931	0.0193	CbGpPWpGaD
Isotretinoin—Vasculitis—Glyburide—gestational diabetes	0.00873	0.0281	CcSEcCtD
Isotretinoin—RARG—head—gestational diabetes	0.00864	0.0514	CbGeAlD
Isotretinoin—RARA—head—gestational diabetes	0.00812	0.0483	CbGeAlD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—LEP—gestational diabetes	0.00726	0.015	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—RETN—gestational diabetes	0.0072	0.0149	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—NAMPT—gestational diabetes	0.00703	0.0146	CbGpPWpGaD
Isotretinoin—Deafness—Glyburide—gestational diabetes	0.00691	0.0222	CcSEcCtD
Isotretinoin—RXRA—Circadian Clock—NAMPT—gestational diabetes	0.00686	0.0142	CbGpPWpGaD
Isotretinoin—Renal failure acute—Glyburide—gestational diabetes	0.0067	0.0215	CcSEcCtD
Isotretinoin—RARA—Adipogenesis—NAMPT—gestational diabetes	0.00661	0.0137	CbGpPWpGaD
Isotretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—gestational diabetes	0.00655	0.0136	CbGpPWpGaD
Isotretinoin—Visual disturbance—Glyburide—gestational diabetes	0.00653	0.021	CcSEcCtD
Isotretinoin—RXRA—Nuclear Receptors—AR—gestational diabetes	0.00652	0.0135	CbGpPWpGaD
Isotretinoin—Renal impairment—Glyburide—gestational diabetes	0.0065	0.0209	CcSEcCtD
Isotretinoin—Dermatitis bullous—Glyburide—gestational diabetes	0.00647	0.0208	CcSEcCtD
Isotretinoin—Arthritis—Glyburide—gestational diabetes	0.00636	0.0205	CcSEcCtD
Isotretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—gestational diabetes	0.00599	0.0124	CbGpPWpGaD
Isotretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—gestational diabetes	0.00588	0.0122	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—ADIPOQ—gestational diabetes	0.00576	0.0119	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—GGCT—gestational diabetes	0.00575	0.0119	CbGpPWpGaD
Isotretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—gestational diabetes	0.00564	0.0117	CbGpPWpGaD
Isotretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—gestational diabetes	0.00564	0.0117	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—ADIPOQ—gestational diabetes	0.00541	0.0112	CbGpPWpGaD
Isotretinoin—Abdominal distension—Glyburide—gestational diabetes	0.00538	0.0173	CcSEcCtD
Isotretinoin—Pancreatitis—Glyburide—gestational diabetes	0.00524	0.0168	CcSEcCtD
Isotretinoin—Sweating increased—Glyburide—gestational diabetes	0.00521	0.0167	CcSEcCtD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.00515	0.0107	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of Androgen receptor activity—AR—gestational diabetes	0.00499	0.0104	CbGpPWpGaD
Isotretinoin—Photosensitivity reaction—Glyburide—gestational diabetes	0.00488	0.0157	CcSEcCtD
Isotretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00465	0.00963	CbGpPWpGaD
Isotretinoin—Agranulocytosis—Glyburide—gestational diabetes	0.00445	0.0143	CcSEcCtD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—gestational diabetes	0.00429	0.00889	CbGpPWpGaD
Isotretinoin—Hepatitis—Glyburide—gestational diabetes	0.00428	0.0138	CcSEcCtD
Isotretinoin—Visual impairment—Glyburide—gestational diabetes	0.00412	0.0133	CcSEcCtD
Isotretinoin—Eye disorder—Glyburide—gestational diabetes	0.004	0.0129	CcSEcCtD
Isotretinoin—Alopecia—Glyburide—gestational diabetes	0.00378	0.0122	CcSEcCtD
Isotretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00377	0.00781	CbGpPWpGaD
Isotretinoin—Malnutrition—Glyburide—gestational diabetes	0.00372	0.012	CcSEcCtD
Isotretinoin—Erythema—Glyburide—gestational diabetes	0.00372	0.012	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.00358	0.00743	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—LEP—gestational diabetes	0.00358	0.00741	CbGpPWpGaD
Isotretinoin—Vision blurred—Glyburide—gestational diabetes	0.00351	0.0113	CcSEcCtD
Isotretinoin—Tremor—Glyburide—gestational diabetes	0.00349	0.0112	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—NAMPT—gestational diabetes	0.00345	0.00714	CbGpPWpGaD
Isotretinoin—Anaemia—Glyburide—gestational diabetes	0.00344	0.0111	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.00344	0.00712	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—LEP—gestational diabetes	0.00336	0.00697	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—gestational diabetes	0.00336	0.00696	CbGpPWpGaD
Isotretinoin—Convulsion—Glyburide—gestational diabetes	0.00323	0.0104	CcSEcCtD
Isotretinoin—Myalgia—Glyburide—gestational diabetes	0.00317	0.0102	CcSEcCtD
Isotretinoin—Arthralgia—Glyburide—gestational diabetes	0.00317	0.0102	CcSEcCtD
Isotretinoin—Confusional state—Glyburide—gestational diabetes	0.00306	0.00985	CcSEcCtD
Isotretinoin—Oedema—Glyburide—gestational diabetes	0.00304	0.00977	CcSEcCtD
Isotretinoin—Shock—Glyburide—gestational diabetes	0.00299	0.00962	CcSEcCtD
Isotretinoin—Nervous system disorder—Glyburide—gestational diabetes	0.00298	0.00958	CcSEcCtD
Isotretinoin—Thrombocytopenia—Glyburide—gestational diabetes	0.00298	0.00957	CcSEcCtD
Isotretinoin—Hyperhidrosis—Glyburide—gestational diabetes	0.00294	0.00945	CcSEcCtD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—gestational diabetes	0.00294	0.00609	CbGpPWpGaD
Isotretinoin—Anorexia—Glyburide—gestational diabetes	0.0029	0.00932	CcSEcCtD
Isotretinoin—Hypotension—Glyburide—gestational diabetes	0.00284	0.00913	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—ADIPOQ—gestational diabetes	0.00282	0.00585	CbGpPWpGaD
Isotretinoin—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.00277	0.0089	CcSEcCtD
Isotretinoin—Paraesthesia—Glyburide—gestational diabetes	0.00273	0.00878	CcSEcCtD
Isotretinoin—Dyspnoea—Glyburide—gestational diabetes	0.00271	0.00871	CcSEcCtD
Isotretinoin—Dyspepsia—Glyburide—gestational diabetes	0.00268	0.0086	CcSEcCtD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—LEP—gestational diabetes	0.00266	0.00552	CbGpPWpGaD
Isotretinoin—Decreased appetite—Glyburide—gestational diabetes	0.00264	0.0085	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Glyburide—gestational diabetes	0.00262	0.00844	CcSEcCtD
Isotretinoin—Feeling abnormal—Glyburide—gestational diabetes	0.0025	0.00805	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Glyburide—gestational diabetes	0.00249	0.00799	CcSEcCtD
Isotretinoin—Urticaria—Glyburide—gestational diabetes	0.00241	0.00776	CcSEcCtD
Isotretinoin—Abdominal pain—Glyburide—gestational diabetes	0.0024	0.00773	CcSEcCtD
Isotretinoin—Hypersensitivity—Glyburide—gestational diabetes	0.00224	0.0072	CcSEcCtD
Isotretinoin—Asthenia—Glyburide—gestational diabetes	0.00218	0.00701	CcSEcCtD
Isotretinoin—Pruritus—Glyburide—gestational diabetes	0.00215	0.00691	CcSEcCtD
Isotretinoin—Diarrhoea—Glyburide—gestational diabetes	0.00208	0.00669	CcSEcCtD
Isotretinoin—RXRA—Biological oxidations—CYP19A1—gestational diabetes	0.002	0.00415	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—AR—gestational diabetes	0.00198	0.00411	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.00196	0.00406	CbGpPWpGaD
Isotretinoin—Vomiting—Glyburide—gestational diabetes	0.00193	0.00621	CcSEcCtD
Isotretinoin—Rash—Glyburide—gestational diabetes	0.00192	0.00616	CcSEcCtD
Isotretinoin—Dermatitis—Glyburide—gestational diabetes	0.00191	0.00616	CcSEcCtD
Isotretinoin—Headache—Glyburide—gestational diabetes	0.0019	0.00612	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.00188	0.00389	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—AR—gestational diabetes	0.00182	0.00376	CbGpPWpGaD
Isotretinoin—Nausea—Glyburide—gestational diabetes	0.00181	0.00581	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.00179	0.00371	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—AR—gestational diabetes	0.00178	0.00369	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—LEP—gestational diabetes	0.00175	0.00363	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—AR—gestational diabetes	0.00171	0.00354	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—AR—gestational diabetes	0.00171	0.00354	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—TNF—gestational diabetes	0.00165	0.00343	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—TNF—gestational diabetes	0.00156	0.00322	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—gestational diabetes	0.00123	0.00255	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.00119	0.00247	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—GCK—gestational diabetes	0.00118	0.00244	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.00114	0.00237	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—GCK—gestational diabetes	0.001	0.00207	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GGCT—gestational diabetes	0.000984	0.00204	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000978	0.00203	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—ADIPOQ—gestational diabetes	0.000969	0.00201	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—AR—gestational diabetes	0.000956	0.00198	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—AR—gestational diabetes	0.00089	0.00184	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—AR—gestational diabetes	0.000874	0.00181	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GLS2—gestational diabetes	0.00086	0.00178	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—AR—gestational diabetes	0.000857	0.00178	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—AR—gestational diabetes	0.000822	0.0017	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—AR—gestational diabetes	0.000822	0.0017	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—TNF—gestational diabetes	0.00081	0.00168	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000769	0.00159	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—LEP—gestational diabetes	0.000602	0.00125	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000596	0.00123	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NAMPT—gestational diabetes	0.000471	0.000977	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GCK—gestational diabetes	0.000468	0.00097	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—FGF2—gestational diabetes	0.000457	0.000948	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—AR—gestational diabetes	0.000428	0.000888	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP19A1—gestational diabetes	0.000342	0.00071	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—TNF—gestational diabetes	0.000279	0.000577	CbGpPWpGaD
